{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Culture virale : Questions médicales les plus fréquentes",
"headline": "Culture virale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Culture virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-13",
"dateModified": "2025-03-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Culture virale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Techniques microbiologiques",
"url": "https://questionsmedicales.fr/mesh/D008828",
"about": {
"@type": "MedicalCondition",
"name": "Techniques microbiologiques",
"code": {
"@type": "MedicalCode",
"code": "D008828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.875"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Méthode des plages virales",
"alternateName": "Viral Plaque Assay",
"url": "https://questionsmedicales.fr/mesh/D010948",
"about": {
"@type": "MedicalCondition",
"name": "Méthode des plages virales",
"code": {
"@type": "MedicalCode",
"code": "D010948",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.875.970.790"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Culture virale",
"alternateName": "Virus Cultivation",
"code": {
"@type": "MedicalCode",
"code": "D014776",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Arvind Varsani",
"url": "https://questionsmedicales.fr/author/Arvind%20Varsani",
"affiliation": {
"@type": "Organization",
"name": "2The Biodesign Center of Fundamental and Applied Microbiomics, School of Life Sciences, Center for Evolution and Medicine, Arizona State University, 1001 S. McAllister Ave, Tempe, AZ 85287-5001 USA."
}
},
{
"@type": "Person",
"name": "Giacomo Fais",
"url": "https://questionsmedicales.fr/author/Giacomo%20Fais",
"affiliation": {
"@type": "Organization",
"name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy."
}
},
{
"@type": "Person",
"name": "Mattia Casula",
"url": "https://questionsmedicales.fr/author/Mattia%20Casula",
"affiliation": {
"@type": "Organization",
"name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy."
}
},
{
"@type": "Person",
"name": "Pierluigi Caboni",
"url": "https://questionsmedicales.fr/author/Pierluigi%20Caboni",
"affiliation": {
"@type": "Organization",
"name": "Department of Life and Environmental Sciences, University of Cagliari, 09042 Cagliari, Italy."
}
},
{
"@type": "Person",
"name": "Giacomo Cao",
"url": "https://questionsmedicales.fr/author/Giacomo%20Cao",
"affiliation": {
"@type": "Organization",
"name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Dosiomics-based detection of dose distribution variations in helical tomotherapy for prostate cancer patients: influence of treatment plan parameters.",
"datePublished": "2024-07-30",
"url": "https://questionsmedicales.fr/article/39080209",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s13246-024-01463-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Alcohol intake exacerbates experimental autoimmune prostatitis through gut microbiota driving cholesterol biosynthesis-mediated Th17 differentiation.",
"datePublished": "2024-07-18",
"url": "https://questionsmedicales.fr/article/39029231",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.intimp.2024.112669"
}
},
{
"@type": "ScholarlyArticle",
"name": "Health-related quality of life in ethnically diverse Black prostate cancer survivors: a convergent parallel mixed-methods approach.",
"datePublished": "2024-07-15",
"url": "https://questionsmedicales.fr/article/39008143",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11136-024-03718-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluating the Expression Levels of Human Endogenous Retrovirus-K 10 (HERV-K10) Gag as a Biomarker in Prostate Cancer Tissue.",
"datePublished": "2024-07-10",
"url": "https://questionsmedicales.fr/article/39130945",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.64275"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 Trial.",
"datePublished": "2024-07-01",
"url": "https://questionsmedicales.fr/article/38980676",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2024.19966"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Techniques d'investigation",
"item": "https://questionsmedicales.fr/mesh/D008919"
},
{
"@type": "ListItem",
"position": 3,
"name": "Techniques de laboratoire clinique",
"item": "https://questionsmedicales.fr/mesh/D019411"
},
{
"@type": "ListItem",
"position": 4,
"name": "Techniques microbiologiques",
"item": "https://questionsmedicales.fr/mesh/D008828"
},
{
"@type": "ListItem",
"position": 5,
"name": "Culture virale",
"item": "https://questionsmedicales.fr/mesh/D014776"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Culture virale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Culture virale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Culture virale",
"description": "Comment se déroule un test de culture virale ?\nQuels échantillons sont utilisés pour la culture virale ?\nQuels tests complètent la culture virale ?\nCombien de temps prend une culture virale ?\nQuels signes indiquent une infection virale dans une culture ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Prostate&page=999#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Culture virale",
"description": "Quels symptômes peuvent indiquer une infection virale ?\nLes symptômes varient selon le virus ?\nComment les symptômes évoluent-ils avec une infection virale ?\nLes symptômes sont-ils toujours présents lors d'une culture virale ?\nQuels symptômes nécessitent une culture virale urgente ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Prostate&page=999#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Culture virale",
"description": "Comment prévenir les infections virales ?\nLes vaccins sont-ils efficaces contre tous les virus ?\nQuelles mesures d'hygiène sont recommandées ?\nLes masques aident-ils à prévenir les infections virales ?\nLes voyages augmentent-ils le risque d'infection virale ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Prostate&page=999#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Culture virale",
"description": "Quels traitements sont disponibles pour les infections virales ?\nLa culture virale aide-t-elle à choisir un traitement ?\nLes antibiotiques sont-ils efficaces contre les virus ?\nComment les antiviraux agissent-ils ?\nLes traitements sont-ils les mêmes pour tous les virus ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Prostate&page=999#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Culture virale",
"description": "Quelles complications peuvent survenir après une infection virale ?\nLes complications sont-elles prévisibles ?\nComment les complications sont-elles traitées ?\nLes enfants sont-ils plus à risque de complications ?\nLes personnes âgées sont-elles plus vulnérables aux complications ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Prostate&page=999#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Culture virale",
"description": "Quels facteurs augmentent le risque d'infection virale ?\nL'âge influence-t-il le risque d'infection virale ?\nLes maladies chroniques augmentent-elles le risque ?\nLe mode de vie influence-t-il le risque d'infection virale ?\nLes voyages à l'étranger augmentent-ils le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Prostate&page=999#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment se déroule un test de culture virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un échantillon est inoculé sur un milieu de culture pour observer la croissance virale."
}
},
{
"@type": "Question",
"name": "Quels échantillons sont utilisés pour la culture virale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les échantillons peuvent inclure du sang, des sécrétions respiratoires ou des biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests complètent la culture virale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et PCR sont souvent utilisés pour confirmer l'infection virale."
}
},
{
"@type": "Question",
"name": "Combien de temps prend une culture virale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La culture virale peut prendre de quelques jours à plusieurs semaines selon le virus."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection virale dans une culture ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'apparition de cytopathies ou de plaques de lyse indique une infection virale."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une infection virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, toux, douleurs musculaires et éruptions cutanées sont fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques selon son tropisme."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec une infection virale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver ou s'améliorer selon la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents lors d'une culture virale ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas nécessairement, certains virus peuvent être asymptomatiques lors de la culture."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une culture virale urgente ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves comme une détresse respiratoire ou une méningite justifient une culture."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections virales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vaccination, hygiène des mains et éviter le contact avec des personnes infectées."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils efficaces contre tous les virus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque vaccin cible des virus spécifiques et leur efficacité varie."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et désinfecter les surfaces fréquemment touchées."
}
},
{
"@type": "Question",
"name": "Les masques aident-ils à prévenir les infections virales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques réduisent la transmission des virus respiratoires."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection virale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à de nouveaux virus et à des épidémies."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les infections virales ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, les immunoglobulines et les traitements symptomatiques sont utilisés."
}
},
{
"@type": "Question",
"name": "La culture virale aide-t-elle à choisir un traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet d'identifier le virus et de déterminer la sensibilité aux antiviraux."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virus ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont efficaces que contre les infections bactériennes."
}
},
{
"@type": "Question",
"name": "Comment les antiviraux agissent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la réplication virale ou modulent la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils les mêmes pour tous les virus ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque virus peut nécessiter un traitement spécifique selon sa biologie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une infection virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la pneumonie, la méningite ou des syndromes post-viraux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles selon le virus et l'état de santé du patient."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles traitées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la complication, allant des soins de soutien à des interventions spécifiques."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains virus peuvent entraîner des complications plus graves chez les enfants."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables aux complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un système immunitaire affaibli, augmentant le risque de complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infection virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un système immunitaire affaibli, le stress, et des conditions de vie insalubres augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'infection virale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus susceptibles aux infections virales."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou les maladies pulmonaires augmentent le risque d'infection."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection virale ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones endémiques expose à des virus non rencontrés localement."
}
}
]
}
]
}
The stability of dosiomics features (DFs) and dose-volume histogram (DVH) parameters for detecting disparities in helical tomotherapy planned dose distributions was assessed. Treatment plans of 18 pro...
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is very common worldwide, and alcohol consumption is a notable contributing factor. Researches have shown that gut microbiota can be influenc...
We first constructed the most-commonly used animal model for CP/CPPS, the experimental autoimmune prostatitis (EAP) model, through immunoassay. Based on this, mice were divided into EAP group and alco...
Alcohol intake increased the proportion of Th17 cells and levels of related inflammatory factors. It also led to an altered gut bacterial richness and increased gut permeability. Further metabolomic a...
Our study is the first to show that alcohol intake promotes Th17 cell differentiation and exacerbates EAP through microbiota-derived cholesterol biosynthesis....
This study examined the health-related quality of life (HRQoL) among ethnically diverse Black men (BM) with prostate cancer (CaP) in the United States....
A convergent parallel mixed-methods design, employing both qualitative and quantitative research, involved recruiting Black CaP survivors through multiple channels. The target population was native-bo...
Black CaP survivors aged 49-85 participated in the study (n = 108), with a subset (n = 31) completing a qualitative interview. Participants were mainly NBBM (72.2%) and treated with radiotherapy (51.9...
Black CaP survivors experienced significant burdens that impacted their overall HRQoL. The analysis revealed impacts on physical, social, and emotional well-being, with variations among ethnic groups ...
Prostate cancer is one of the most common major health problems. Several risk factors are potentially involved in its development. Therefore, a biomarker capable of early diagnosis is necessary to fac...
The presence of bone pain is significantly associated with worse overall survival (OS) in patients with castration-resistant prostate cancer. However, there are few data regarding bone pain and surviv...
To compare survival outcomes among patients with MHSPC by presence or absence of baseline bone pain at diagnosis....
This post hoc secondary analysis, conducted from September 1 to December 31, 2023, used patient-level data from SWOG-1216, a phase 3, prospective randomized clinical trial that enrolled patients with ...
In the SWOG-1216 trial, patients were randomized (1:1) to receive either androgen deprivation therapy (ADT) with orteronel, 300 mg orally twice daily (experimental group), or ADT with bicalutamide, 50...
Overall survival was the primary end point; progression-free survival (PFS) and prostate-specific antigen (PSA) response were secondary end points. Cox proportional hazards regression models were used...
Of the 1279 male study participants, 301 (23.5%) had baseline bone pain at MHSPC diagnosis and 896 (70.1%) did not. Bone pain status was unavailable in 82 patients (6.4%). The median age of the 1197 p...
In this post hoc secondary analysis of the SWOG-1216 randomized clinical trial, patients with baseline bone pain at MHSPC diagnosis had worse survival outcomes than those without bone pain. These data...
ClinicalTrials.gov Identifier: NCT01809691....
Disulfidptosis, a newly identified programmed cell death pathway in prostate cancer (PCa), is closely associated with intracellular disulfide stress and glycolysis. This study aims to elucidate the ro...
Surrogate endpoints are becoming increasingly important in health technology assessment, where decisions are based on complex cost-effectiveness models (CEMs) that require numerous input parameters. D...
Prostate-specific membrane antigen radioguided surgery (PSMA-RGS) might identify lymph node invasion (LNI) in prostate cancer (PCa) patients undergoing extended pelvic lymph node dissection (ePLND). T...
Ad interim analyses which focused on 30 patients with available pathological information were conducted. All patients underwent preoperative PSMA positron emission tomography (PET). 99m-Technetium-PSM...
Overall, 9 (30%) patients had LNI, with 22 (13%) and 80 (11%) positive regions and lymph nodes, respectively. PSMA-RGS showed uptakes in 12 (40%) vs. 7 (23%) vs. 6 (20%) patients for a TtB ratio ≥ 2 v...
PSMA-RGS using a TtB ratio ≥ 2 to identify suspicious nodes, could allow to spare > 50% ePLNDs and would identify additional pN1 patients compared to PSMA PET and higher TtB ratios....
This phase II nonrandomized study evaluated the efficacy and safety of AZD4635 in combination with durvalumab (Arm A) or durvalumab plus cabazitaxel (Arm B) in patients with metastatic castration-resi...
The primary endpoint was radiographic progression-free survival (rPFS) per RECIST v1.1 (soft tissue) or the Prostate Cancer Clinical Trials Working Group 3 (bone). Secondary endpoints included safety,...
In the final analysis (1 November 2021), 30 patients were treated (Arm A, n = 2; Arm B, n = 28). The median rPFS in Arm B was 5.8 months (95% confidence interval 4.2-not calculable). Median rPFS was 5...
Although the safety profile of both combinations was consistent with known safety data of the individual agents, the results of this trial do not support further development of the combinations....